An unexpected role of the tumor suppressor p53 was recently discovered in a therapy-resistant melanoma subpopulation; p53 is stabilized by Wnt signaling, leading to the slow-cycling phenotype, one of the recently recognized hallmarks of BRAFi/MEKi therapy resistance [28]. The gene discussed is TP53; the disease is melanoma.